Technology Improving Medication-Assisted Treatment in Primary Care

UCLA researchers and their industry partner Q2i received funding from NIH/NIDA Grant Number 1R42DA050398-01 to measure the efficacy and potential of specialized technology (OARS) in increasing availability of medication-assisted treatment, specifically Suboxone (buprenorphine/naloxone), initiation and adherence, and ultimately opioid abstinence, in primary care settings.

According to new data released by the Centers for Disease Control and Prevention, more than 93,000 people died of a drug overdose in the U.S. last year — a record number that reflects a rise of nearly 30% from 2019. The opioid epidemic has become North America’s most widespread behavioral public health problem. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious.

The Opioid Addiction Recovery Support (OARS) comprises of a healthcare team portal connected to a patient mobile application, to provide opioid related education, promote connectedness with clinicians, and track MAT treatment progress. This STTR Fast Track proposal will conduct interviews with patients that will inform optimal design of OARS and utilize a “stepped wedge” effectiveness design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes in primary care settings and evaluate sustainability and return on investment.

About OARS

OARS is an existing Q2i company technology that has been in use for over 2 years. Early-stage feedback from patients and providers indicates improved provider experience, high levels of patient engagement, greater adherence to treatment plans, and increased program retention/reduced drop out. The solution is also improving coordination of care. This study will collect empirical evidence on these improvements.

FeaturesBenefits to:
ComponentHealthcare TeamPatient
Utox ResultsTracking, visualization and trend analysis of test results Analyze patient Utox, share with patients, increasing ownership of treatment plan View and keep track of Utox results and encourage treatment adherence
AttendanceView of patient’s attendance and punctuality Log and track patient’s attendance at appointments and group meetings; get consolidated view of patient attendance to spot issues earlierView meeting and appointment attendance records to reduce missed appointments and encourage treatment adherence
ParticipationDisplays patient’s engagement levelsLog, share and track patient’s responsiveness at appointments and group meetingsView feedback from the healthcare team
MATRAA dynamic risk score indicating a patient’s likelihood to dropout/ relapseIdentify most at-risk patients and flag for investigation/ intervention to improve treatment outcomes Healthcare team gains greater insight into patient’s recovery; earlier intervention with at-risk patients improves chances of maintaining recovery
JournalA daily feedback of patient’s emotions View and respond to patient’s daily feedback on feelings, challenges, coping Securely log and share thoughts, stay connected and supported between visits
Healthcare DirectSecure messaging channel between patients and cliniciansTimely communication improves treatment adherenceTimely communication improves patient satisfaction, treatment adherence
Education ContentRepository of all digital assets relating to the programPost and share informative documents and videos to the patient’s app to motivate and educate View material relevant to the treatment plan such as relapse prevention strategies
Calendar and EventsAppointments and events Easily manage scheduled patient appointments and reminders; improve patient attendanceView upcoming appointment, get reminders; improve attendance
SurveysCreate or upload custom surveys for patients to completeCollect valuable data and feedback to refine / improve treatment protocolsGives feedback to help providers improve services

OARS Provider Dashboard

OARS Patient App

UCLA and Q2i are seeking primary care clinicians who run a MAT (Suboxone) program from their primary care clinic to treat OUD.


Use OARS technology with their MAT patients for a minimum of 8 months

The study has 6 start date options starting in 2020

     Incentives available:

    $ 6,000 per clinic

    Free use of OARS technology post study for up to 2 years

      If you are interested in participating, please complete this form and we will reach out to you with further details: